Cargando…
Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
BACKGROUND: Memantine has shown effects on cortical metabolism in Alzheimer’s disease (AD), and the mechanism of action may not be specific to AD alone. We hypothesized that participants with frontotemporal dementia taking memantine would show an increased cortical metabolic activity in frontal regi...
Autores principales: | Chow, Tiffany W, Graff-Guerrero, Ariel, Verhoeff, Nicolaas PLG, Binns, Malcolm A, Tang-Wai, David F, Freedman, Morris, Masellis, Mario, Black, Sandra E, Wilson, Alan A, Houle, Sylvain, Pollock, Bruce G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140294/ https://www.ncbi.nlm.nih.gov/pubmed/21792308 http://dx.doi.org/10.2147/NDT.S22635 |
Ejemplares similares
-
Comparison of manual and semi-automated delineation of regions of interest for radioligand PET imaging analysis
por: Chow, Tiffany W, et al.
Publicado: (2007) -
Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT(2A)) receptors in older, healthy adults
por: Chow, Tiffany W, et al.
Publicado: (2009) -
Amyloid deposition in semantic dementia: a positron emission tomography study
por: Brown, Eric E., et al.
Publicado: (2016) -
Memantine for the treatment of frontotemporal dementia: a meta-analysis
por: Kishi, Taro, et al.
Publicado: (2015) -
Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study
por: Beyer, Leonie, et al.
Publicado: (2020)